-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 43 approved new animal drug applications (NADAs) and 3 approved abbreviated new animal drug applications (ANADAs) from Boehringer Ingelheim Vetmedica, Inc. to Strategic Veterinary Pharmaceuticals, Inc.
DATES:
This rule is effective April 9, 2013.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Steven D. Vaughn, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240-276-8300, email: steven.vaughn@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Boehringer Ingelheim Vetmedica, Inc., 2621 North Belt Highway, St. Joseph, MO 64506-2002 has informed FDA that it has transferred ownership of, and all rights and interest in, the following 43 approved NADAs and 3 approved ANADAs to Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503:
Table 1.—Applications Transferred
Application No. Trade name 11-531 DIZAN (dithiazanine iodide) Tablets. 11-674 DIZAN (dithiazanine iodide) Powder. 12-469 DIZAN Suspension With Piperazine. 31-512 ATGARD (dichlovos) Swine Wormer Type A Medicated Article. 33-803 TASK (dichlovos) Dog Anthelmintic. 35-918 EQUIGARD (dichlovos). 38-200 MEDAMYCIN (oxytetracycline hydrochloride) Soluble Antibiotic. 39-483 BIO-TAL (thiamylal sodium) Injectable Solution. 40-848 ATGARD C (dichlovos) Swine Wormer Type A Medicated Article. 43-606 ATGARD V (dichlovos) Swine Wormer Type A Medicated Article. 45-143 OXYJECT (oxytetracycline hydrochloride) Injectable Solution. 47-278 OXY-TET 50 (oxytetracycline hydrochloride) Injectable Solution. 47-712 BIZOLIN-100 (phenylbutazone) Tablets. 48-010 ANAPLEX (dichlorophene and toluene) Capsules. 48-237 EQUIGEL (dichlovos) Oral Gel. 48-271 TASK (dichlovos) Tablets. 49-032 ATGARD C (dichlovos) 9.6% Type A Medicated Article. 55-097 DRY-MAST (penicillin G procaine/dihydrostreptomycin sulfate) Intramammary Infusion. 65-178 FERMYCIN (chlortetracycline hydrochloride or chlortetracycline bisulfate) Soluble Powder. 65-461 ANACETIN (chloramphenicol) Tablets. 65-481 Chlortetracycline Pneumonia/Calf Scour Boluses. 65-486 Chlortetracycline Bisulfate Soluble Powder. 65-491 MEDICHOL (chloramphenicol) Tablets. 65-496 Tetracycline Soluble Powder. 92-837 NEMACIDE (diethylcarbamazine citrate) Oral Syrup. 93-516 BIZOLIN (phenylbutazone) Injection 20%. 97-452 OXYJECT 100 (oxytetracycline hydrochloride) Injectable Solution. 98-569 MEDACIDE-SDM (sulfadimethoxine) Injection 10%. 99-618 BIZOLIN (phenylbutazone) 1-G Tablets. 108-963 MEDAMYCIN (oxytetracycline hydrochloride) Injectable Solution. Start Printed Page 21059 109-305 Oxytocin Injection. 117-689 NEUROSYN (primidone) Tablets. 125-797 Nitrofurazone Dressing. 126-236 Nitrofurazone Soluble Powder. 126-676 D & T (dichlorophene and toluene) Worm Capsules. 127-627 NEMACIDE-C (diethylcarbamazine citrate) Tablets. 128-069 NEMACIDE (diethylcarbamazine citrate) Chewable Tablets. 132-028 ANESTATAL (thiamylal sodium) Powder for Injection. 135-771 Methylprednisolene Tablets. 136-212 Methylprednisolone Acetate Injectable Suspension. 137-310 Gentamicin Sulfate Injectable Solution. 138-869 Triamcinolone Acetonide Injectable Suspension. 140-442 Xylazine HCl Injection. 200-023 Gentamicin Sulfate Intrauterine Solution. 200-029 Ketamine Hydrochloride Injection. 200-165 SDM (sulfadimethoxine) 12.5% Oral Solution. Accordingly, the Agency is amending the regulations in 21 CFR parts 510, 520, 522, 524, 526, 529, and 558 to reflect the transfer of ownership.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects
21 CFR Part 510
- Administrative practice and procedure
- Animal drugs
- Labeling
- Reporting and recordkeeping requirements
21 CFR Parts 520, 522, 524, 526, and 529
- Animal drugs
21 CFR Part 558
- Animal drugs
- Animal feeds
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, 524, 526, 529, and 558 are amended as follows:
Start PartPART 510—NEW ANIMAL DRUGS
End Part Start Amendment Part1. The authority citation for 21 CFR part 510 continues to read as follows:
End Amendment Part Start Amendment Part2. In the table in paragraph (c)(1) of § 510.600, alphabetically add an entry for “Strategic Veterinary Pharmaceuticals, Inc.”; and in the table in paragraph (c)(2), numerically add an entry for “054628” to read as follows:
End Amendment PartNames, addresses, and drug labeler codes of sponsors of approved applications.* * * * *(c) * * *
(1) * * *
Firm name and address Drug labeler code * * * * * Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503 054628 * * * * * (2) * * *
Drug labeler code Firm name and address * * * * * 054628 Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503 * * * * * PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part3. The authority citation for 21 CFR part 520 continues to read as follows:
End Amendment Part[Amended]4. In paragraph (b)(1)(i) of § 520.390a, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]5. In paragraph (b)(3) of § 520.441, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]6. In paragraph (b) of § 520.443, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]7. In paragraph (b)(2), remove “000010 and 000061” and in its place add “Nos. 000061 and 054628”.
End Amendment Part[Amended]8. In paragraph (c) of § 520.600, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]9. In paragraph (a)(6) of § 520.622a, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]10. In paragraph (c)(2) of § 520.622b, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]11. In paragraph (b)(6) of § 520.622c, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]12. In § 520.763a, remove and reserve paragraph (a); in paragraph (c), remove “000010” and in its place add “054628”; and remove paragraph (e).
End Amendment Part[Amended]13. In § 520.763b, remove and reserve paragraph (a); and in paragraph (c), remove “000010” and in its place add “054628”.
End Amendment Part[Amended]14. In paragraph (b) of § 520.763c, remove “000010” and in its place add “054628”; and remove and reserve paragraph (c).
End Amendment Part Start Amendment Part15. In paragraph (b) of § 520.1408, remove “000010” and in its place add “054628”; and remove and reserve paragraph (c).
End Amendment Part[Amended]16. In § 520.1660d:
End Amendment Part Start Amendment Parta. In paragraph (b)(3), remove “000010” and in its place add “054628”.
End Amendment Part Start Amendment Partb. In paragraph (d)(1)(ii)(A)( 3), remove “000010” and in its place add “054628”.
End Amendment Part Start Amendment Partc. In paragraph (d)(1)(ii)(B)( 3), remove “000010” and in its place add “054628”.
End Amendment Part Start Amendment Partd. In paragraph (d)(1)(ii)(C)( 3), remove “000010” and in its place add “054628”.
End Amendment Part[Amended]17. In paragraph (b)(2) of § 520.1720a, remove “000010 and 000859” and in its place add “000859 and 054628”.
End Amendment Part[Amended]18. In paragraph (b) of § 520.1900, remove “000010” and in its place add “054628”; and in paragraphs (c)(1), (c)(2), and (c)(3), remove the footnote.
End Amendment Part[Amended]19. In paragraph (a)(1) of § 520.2220a, remove “000010, 000069, 000859, 054925, and 057561” and in its place add “000069, 000859, 054628, 054925, and 057561”.
End Amendment Part[Amended]20. In paragraph (b)(2) of § 520.2345d, remove “000010” and in its place add “054628”.
End Amendment Part Start PartPART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part21. The authority citation for 21 CFR part 522 continues to read as follows:
End Amendment Part[Amended]22. In paragraph (b)(3) of § 522.1044, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]23. In paragraph (b) of § 522.1222a, remove “000010, 000859, 061690, 026637, and 063286” and in its place add “000859, 026637, 054628, 061690, and 063286”.
End Amendment Part[Amended]24. In paragraph (b) of § 522.1410, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]25. In paragraphs (a)(2), (b)(2), (g)(2), and (h)(2) of § 522.1662a, remove “000010” and in its place add “054628”.
End Amendment Part Start Amendment Part26. In § 522.1680, revise the section heading to read as set forth below; and in paragraph (b), remove “000010, 000856, 000859, and 061623” and in its place add “000856, 000859, 054628, and 061623”.
End Amendment Part Start Amendment Part27. In § 522.1720, revise the section heading to read as set forth below; and in paragraph (b)(2), remove “000010” and in its place add “054628”.
End Amendment Part Start Amendment Part28. In § 522.2220, revise the section heading as set forth below; and in paragraph (c)(2), remove “000010” and in its place add “054628”.
End Amendment PartSulfadimethoxine.* * * * *Start Amendment Part29. In § 522.2424, revise the section heading as set forth below; and in paragraph (b), remove “000010 and 000856” and in its place add “000856 and 054628”; and remove paragraph (c)(4).
End Amendment Part[Amended]30. In paragraph (b) of § 522.2483, remove “000010” and in its place add “054628”.
End Amendment Part[Amended]31. In paragraph (b)(1) of § 522.2662, remove “000010” and in its place add “054628”.
End Amendment Part Start PartPART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part32. The authority citation for 21 CFR part 524 continues to read as follows:
End Amendment Part[Amended]33. In paragraph (b)(1) of § 524.1580b, remove “000010, 000069, 050749, 054925, 058005, and 061623” and in its place add “000069, 050749, 054628, 054925, 058005, and 061623”.
End Amendment Part[Amended]34. In paragraph (b) of § 524.1580c, remove “000010 and 000069” and in its place add “000069 and 054628”.
End Amendment Part Start PartPART 526—INTRAMAMMARY DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part35. The authority citation for 21 CFR part 526 continues to read as follows:
End Amendment Part[Amended]36. In paragraph (b) of § 526.1696b, remove “000010” and in its place add “054628”.
End Amendment Part Start PartPART 529—CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part37. The authority citation for 21 CFR part 529 continues to read as follows:
End Amendment Part[Amended]38. In paragraph (b) of § 529.1044a, remove “000010, 000061, 000856, 000859 057561, 058005, and 061623” and in its place add “000061, 000856, 000859, 054628, 057561, 058005, and 061623”.
End Amendment Part Start PartPART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
End Part Start Amendment Part39. The authority citation for 21 CFR part 558 continues to read as follows:
End Amendment Part[Amended]40. In paragraph (a) of § 558.205, remove “000010” and in its place add “054628”.
End Amendment Part Start SignatureDated: March 26, 2013.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 2013-07542 Filed 4-8-13; 8:45 am]
BILLING CODE 4160-01-P
Document Information
- Comments Received:
- 0 Comments
- Effective Date:
- 4/9/2013
- Published:
- 04/09/2013
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 2013-07542
- Dates:
- This rule is effective April 9, 2013.
- Pages:
- 21058-21060 (3 pages)
- Docket Numbers:
- Docket No. FDA-2013-N-0002
- Topics:
- Administrative practice and procedure, Animal drugs, Animal feeds, Labeling, Reporting and recordkeeping requirements
- PDF File:
- 2013-07542.pdf
- Supporting Documents:
- » FREEDOM OF INFORMATION SUMMARY NADA 130-185 AMPROL 25% and FLAVOMYCIN Amprolium and Bambermycins
- » FREEDOM OF INFORMATION SUMMARY Application Number 141-422 PACCAL VET-CA1 Paclitaxel for injection Powder for Injection Dog
- » FREEDOM OF INFORMATION SUMMARY NADA141-420 TILDREN tiludronate disodium Powder for injection Horse
- » FREEDOM OF INFORMATION SUMMARY NADA 141-361 PULMOTIL AC Tilmicosin Phosphate Aqueous Concentrate Swine
- » FREEDOM OF INFORMATION SUMMARY NADA 141-246 AQUAFLOR Florfenicol
- » Freedom of Information Summary NADA 141-288 EXCENEL RTU EZ Ceftiofur Hydrochloride
- » Freedom of Information Summary NADA 095-735 RUMENSIN 90 Monensin
- » Freedom of Information Summary NADA 141-406 NEXGARD Afoxolaner Chewable Tablet
- » Freedom of Information Summary ANADA 200-548 ACTOGAIN 45 Ractopamine Hydrochloride Cattle fed in confinement for slaughter
- » Freedom of Information Summary ANADA 200-542 ENGAIN 9 and ENGAIN 5 Ractopamine Hydrochloride Finishing Swine
- CFR: (33)
- 21 CFR 510.600
- 21 CFR 520.441
- 21 CFR 520.443
- 21 CFR 520.580
- 21 CFR 520.600
- More ...